Adcetris Maker Launches Trials for New Agent Against ALL and B-Cell NHL

Seattle Genetics, maker of the antibody drug conjugate Adcetris, has announced the initiation of a pair of Phase I clinical trials testing the company's latest oncology candidate, SGN-CD19A.

Each trial will serve to assess the safety and anti-tumor response of SGN-CD19A against both CD19-positive acute lymphoblastic leukemia (ALL) as well as B-cell non-Hodgkin's lymphoma (HL).

Primary endpoints of the trials include determining the maximum tolerated dose as well as investigating the safety of SGN-CD19A. Secondary endpoints will include antitumor activity, pharmacokinetics, progression-free survival (PFS) and overall survival (OS).

Adcetris, the company's only approved drug, generated more than $100 million during the first nine months of 2012 and is now approved under Health Canada's Notice of Compliance with conditions (NOC/c) for the treatment of relapsed or refractory Hodgkin's as well as systemic anaplastic large cell lymphoma (sALCL) - conditions for which it is approved by the U.S. FDA as well.

Most recently, a global phase III study known as ECHELON-2 was launched, investigating Adcetris plus chemotherapy as a potential first-line therapy against CD30-positive mature T-cell lymphoma (MTCL).

ECHELON-2 was initiated in January. 

Source: Leukemia & Lymphoma Society

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...